Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,100,000
in 1 filing

Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brennan David R −$3.1M Director sold 39% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +3,454 $28.88 $100K 120,935
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +3,454 $24.70 $85K 201,120
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +3,454 $34.03 $118K 231,648
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +3,454 $26.46 $91K 260,148
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +3,454 $26.43 $91K 303,048
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +3,454 $17.07 $59K 326,613
2024-05-28 Bonstein Sara Chief Financial Officer Sale 10b5-1 −20,724 $50.01 $1.0M 338,045
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,454 88,186
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,454 31,436
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,454 42,146
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,454 65,186
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,454 59,386
2024-05-28 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,454 91,506
2024-05-17 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −4,642 $25.09 $116K 106,134
2024-05-17 Adsett Roger Chief Operating Officer Sale 10b5-1 −5,945 $25.09 $149K 149,275
2024-05-14 Wise John Drayton Chief Commercial Officer Sale −5,088 $25.47 $130K 123,259
2024-05-14 Smith Michael Alexander Chief Legal Officer Sale −5,093 $25.40 $129K 94,579
2024-05-14 Schaeffer Orlov S Nicole Chief People Strategy Officer Sale −6,508 $25.53 $166K 108,760
2024-05-14 Lewis William Chair and CEO Sale −22,198 $25.52 $566K 384,125
2024-05-14 Flammer Martina M.D. Chief Medical Officer Sale −10,640 $25.47 $271K 110,776

Page 40 of 42 · 826 trades